Content

    1. Clinical Trials 101

    2. Practical Pearls for Trial Recruitment

    3. Disparities in Clinical Research

    4. Clinical Trials Drug Development for all Ages

    5. The Road to Glomerular Disease Therapeutics

    6. Fireside chat with Dr. Aliza Thomson

    7. Pathology and Clinical Trials

    8. Immune Tolerance Network and The Advancement of Clinical therapies: A Closer Look at Membranous Nephropathy

    1. IgA Nephropathy

    2. Emerging Therapies for IgA Nephropathy

    3. IgAN & FSGS

    4. IgA Nephropathy: Developing a Non-Immunosuppressive Therapy

    1. FSGS (I)

    2. FSGS (II)

    3. Targeting the Podocyte as a Treatment Approach for FSGS

    4. IgAN & FSGS

    5. A Clinical Trial in Primary FSGS

    6. Emerging Science in Kidney Disease with Pfizer

    1. Advances in APOL1 Therapeutics

    2. APOL1: A Story from Bench to Bedside

    1. Lupus Nephritis

    2. Lupus Nephritis Trial Design and Execution

    1. C3 Glomerulopathy

    2. Targeting C3 and IC Glomerulopathies: Pegcetacoplan